Nagoya Protocol Explained: Access and Benefit Sharing | ABS Guide

Added:

Scientific 'Bioparalysis' and Regulatory Overburden

While the Nagoya Protocol aims to prevent biopiracy and ensure equitable benefit-sharing, critics from the scientific community argue that it has led to 'bioparalysis.' The protocol's highly bureaucratic, complex, and fragmented national implementation processes have significantly increased transaction costs and legal uncertainties for researchers. This hinders non-commercial academic research, international collaborations, and biodiversity conservation efforts. Furthermore, public health experts warn that rigid ABS regulations can delay the sharing of crucial pathogen samples during global health crises. By applying a commercial transaction model to all genetic research, the protocol inadvertently obstructs scientific progress that could otherwise serve the global public good.

The Convention on Biological Diversity (CBD): Understanding its history, structure, and its three primary objectives, particularly the third objective on access and benefit-sharing.
Concepts of Bioprospecting and Biopiracy: Familiarity with how scientific researchers and corporations search for and utilize biological resources, and the ethical issues surrounding unauthorized exploitation.
Sovereignty over Natural Resources: The international legal principle that nations have the sovereign right to exploit and regulate their own biological and genetic resources.
Traditional Ecological Knowledge (TEK): Understanding how indigenous and local communities develop and maintain knowledge about local biodiversity, and how this knowledge is historically vulnerable to appropriation.
The Digital Sequence Information (DSI) Debate: Exploring how open-access digital genetic databases challenge the physical access-and-benefit-sharing frameworks of the Nagoya Protocol.
National ABS Legislation and Compliance: Analyzing how different sovereign nations translate the international treaty into domestic laws (e.g., India's Biological Diversity Act vs. EU regulations).
WIPO and Intellectual Property: Investigating the World Intellectual Property Organization's efforts to create international legal instruments protecting Traditional Knowledge and Genetic Resources.
Corporate Compliance and Due Diligence: Understanding the operational challenges biotechnology, pharmaceutical, and cosmetic industries face in tracking genetic material supply chains.
The Kunming-Montreal Global Biodiversity Framework (GBF): Studying the post-2020 international targets that build upon the Nagoya Protocol to halt biodiversity loss by 2030.
363 views3likes26:01@absbiotrade170Original Release: 2016-06-21

The Nagoya Protocol, adopted in October 2010, establishes legally binding international rules for the fair and equitable sharing of benefits arising from the utilization of genetic resources and associated traditional knowledge, requiring prior informed consent from provider countries and mutually agreed terms for benefit sharing, as demonstrated through case studies of teff (Ethiopia), hoodia (South Africa), and argan (Morocco).